Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 2,602.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 85,462 shares of the financial services provider’s stock after buying an additional 82,300 shares during the period. Caisse DE Depot ET Placement DU Quebec’s holdings in CME Group were worth $18,857,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Harbor Capital Advisors Inc. raised its stake in shares of CME Group by 0.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after acquiring an additional 45 shares in the last quarter. CVA Family Office LLC grew its holdings in CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the last quarter. Lester Murray Antman dba SimplyRich increased its position in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares in the last quarter. Zions Bancorporation N.A. lifted its holdings in shares of CME Group by 3.7% during the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after purchasing an additional 54 shares during the last quarter. Finally, Quent Capital LLC boosted its position in shares of CME Group by 10.2% in the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after purchasing an additional 55 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.
CME Group Trading Up 0.3 %
CME Group stock opened at $238.00 on Monday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market cap of $85.77 billion, a PE ratio of 25.03, a P/E/G ratio of 5.49 and a beta of 0.55. The stock’s 50 day simple moving average is $225.55 and its two-hundred day simple moving average is $211.96. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $238.97.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 1.93%. CME Group’s payout ratio is 48.37%.
Insiders Place Their Bets
In related news, Director Martin J. Gepsman sold 400 shares of the firm’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total value of $89,168.00. Following the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This trade represents a 1.57 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 8,028 shares of company stock worth $1,811,681. 0.30% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on CME shares. Redburn Atlantic lowered CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price on the stock. in a research report on Tuesday, October 8th. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a report on Thursday, October 24th. Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Deutsche Bank Aktiengesellschaft cut their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, TD Cowen assumed coverage on shares of CME Group in a research note on Thursday, September 26th. They set a “hold” rating and a $221.00 price objective for the company. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and an average target price of $224.47.
View Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- 3 Monster Growth Stocks to Buy Now
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- Utilities Stocks Explained – How and Why to Invest in Utilities
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.